Vimta Labs Ltd Share Price

₹600.50 5.90 (0.99%) BSE
as updated on 12-Dec-2025 16:59 | Sector - Miscellaneous

Day Range

  • Day's Low:594.85
  • Day's High:603.90

  • 52 Week Low372.50
  • 52 Week High902.85

Vimta Labs Ltd's key Fundamentals

Market Cap ₹2,680 Cr.
P/E Ratio 36.1
TTM EPS 16.6
P/B Ratio 6.44
ROE 19.13
Debt to Equity 0.02
Face Value 2
BVPS 93.3
3 Year Sales Growth 7.62%

Vimta Labs Ltd's Share Price Returns

1 Day 0.99%
1 Week -0.20%
1 Month -5.90%
3 Months -24.40%
6 Months 24.10%
1 Years 25.60%
3 Years 183.20%
5 Years 549.30%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Vimta Labs Ltd Shareholding Pattern

Promoters

(35.99%)

Institutions

(5.20%)

Non-Institutions

(58.80%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Vimta Labs Ltd

Vimta Labs is India’s leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe.

Vimta supports regulatory authorities in mandatory certification of food and agri products exported from India. Vimta assists the food industry commissions for nutritional labelling, food safety evaluations, trace analysis and shelf life studies.

Vimta has a team of 684 professionals comprising 446 scientists in various disciplines such as chemistry, pharma, medicine, microbiology, molecular biology and informatics. The team is slated to double in next three years.

Vimta is a multi-site organization with more than 300,000 sqft world class laboratory facilities. The technologies deployed at Vimta are current and leading edge, duly validated.

Vimta has over 12 years of experience in providing preclinical services to Pharma companies world-wide accordance with the guidelines prescribed by international agencies.

Vimta has a state-of-art building of Class 10,000 Pre-clinical facility with a total built up area of 33,000 sq.ft. with 32 rodent experimental rooms, 5 procedure rooms, separate quarantine facility and distinct non-rodent facility with 48 SS kennels with a comfortable perch, liberal exercise area.

It provides services in pharmacology, toxicology and DMPK areas. The toxicology services include but not limited to in-vivo and in-vitro genotoxicity, acute to chronic toxicity, carcinogenicity, reproductive toxicity studies, safety pharmacology, and immunotoxicology. Pharmacology services are available in various therapeutics areas such as pain & inflammation, metabolic disorders, respiratory, CNS, and xenograft & allograft models for oncology. In addition to the regulatory studies we use tailor-made in vitro and in vivo ADME techniques to help profile your drug candidate in both rodent and non-rodent animals models.

Services offered by the company:

  • Advanced Molecular Biology
  • Food and Agriculture
  • Drugs & Pharma
  • Water
  • Environmental Assessments
  • Clinical Research
  • Clinical Reference Lab Services
  • Preclinical Research
  • Genomics Online Ordering

 Achievements/ recognition

  •    NABL as per ISO 15189:2007
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 594.85
  • Day's High: 603.90

  • 52 Week Low372.50
  • 52 Week High902.85

Vimta Labs Ltd's key Fundamentals

Market Cap ₹2,680 Cr.
P/E Ratio 36.1
TTM EPS 16.6
P/B Ratio 6.44
ROE 19.13
Debt to Equity 0.02
Face Value 2
BVPS 93.3
3 Year Sales Growth 7.62%

Vimta Labs Ltd's Share Price Returns

1 Day 0.99%
1 Week -0.20%
1 Month -5.90%
3 Months -24.40%
6 Months 24.10%
1 Years 25.60%
3 Years 183.20%
5 Years 549.30%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×